Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study
Clinical trial NCT06868030 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06868030
- Sponsor
- First Hospital of China Medical University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.